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Introduction
============

Anterior mediastinal mass (AMM) is common in pediatric age, but the incidence is unknown \[[@REF1]\]. AMM in children has varied presentations from asymptomatic to life-threatening events like respiratory arrest or cardiovascular collapse and even death. The most common presentations of childhood AMM are similar to symptoms and signs seen in common respiratory illnesses \[[@REF2]\]. Several clinical reports described life-threatening events in AMM in children during treatment, especially related to procedures or postural changes either as acute respiratory or cardiovascular compromise \[[@REF3],[@REF4]\]. Children are more vulnerable due to a small thoracic cavity size, more compressible cartilaginous structure of the airway, and higher oxygen consumption rate with little reserve \[[@REF5]\]. AMM in children is challenging, and sometimes a nightmare situation for pediatric oncologists and pediatric intensivists. A study described one spectrum of childhood AMM presenting with respiratory symptoms and signs or symptoms and signs of superior vena cava syndrome, presence of pleural effusion and/or pericardial effusion or radiological evidences of compression/deviation of the airway or great vessel as critical mediastinal mass syndrome (CMMS) \[[@REF6]\]. These cases need a multidisciplinary team approach for diagnostic, therapeutic, and supportive care to improve the outcome and avoid preventable complications to decrease morbidity and mortality \[[@REF7],[@REF8]\].

Published research on CMMS is limited; hence, we investigated these cases in the present study to determine the mortality and morbidity in CMMS. Our secondary aim was to determine the clinicopathological profile of these patients.

Materials and methods
=====================

A retrospective cohort study was done from April 2017 to September 2019 at the Pediatric Intensive Care Unit (PICU) of a tertiary-care center with a very high burden of pediatric oncology patients, registering more than 800 new cancers in children annually. The study participants included all children (age range: 1 month-16 years) with anterior mediastinal mass presenting acutely with cardiorespiratory symptoms being admitted in PICU. Age, gender, ethnicity, weight, nutritional status, duration of illness along with clinical variables and outcome variables (morbidity \[defined complications occurred in PICU\], and mortality as death in the same admission) were collected on a structured data collection sheet. Patients confidentiality was maintained. This study aimed to determine the clinicopathological profile and outcomes of CMMS. Ethical approval to conduct the study was obtained from the Institutional Review Board of the Indus Hospital (IRD_IRB_2019_09_012).

CMMS was defined as a mass in the anterior mediastinum that causes respiratory signs and symptoms, signs of superior vena cava syndrome, radiological evidence of compression, deviation of the airway, or great vessel or presence of pleural/pericardial effusion \[[@REF6]\]. Hyperleukocytosis was defined as a peripheral white blood cell count greater than 100,000/mL. Morbidity was defined as a respiratory failure (use of mechanical ventilation), sepsis (empirical use of broad-spectrum antibiotics \[vancomycin, meropenem, and colistin\] with clinical suspicion of sepsis), shock (use of any inotrope or vasopressor), acute kidney injury (rise in serum creatinine based on Kidney Disease: Improving Global Outcomes \[KDIGO\] criteria) and tumor lysis syndrome (laboratory or clinical based on Bishop's criteria) \[[@REF9],[@REF10]\].

Data were entered into and analysed using the Statistical Package for the Social Sciences (SPSS), version 22 (IBM Corp., Armonk, NY). Means and standard deviations were calculated for continuous variables such as age, laboratory characteristics, and length of hospital stay. Frequency and proportions were used for categorical variables such as gender, and clinical and laboratory characteristics. Simple descriptive statistics were applied. Univariate logistic regression analysis was performed to assess the ability of variables such as age, gender, nutritional status, duration of symptoms, diagnosis, and laboratory findings including, total leukocyte count and platelet count, to predict the mortality outcome.

Results
=======

Of the total 221 mediastinal mass cases, 61 (27.6%) children were enrolled during the study period. The mean age was 9 ± 3.34 years, and there was a male predominance (68.9%); 65.6% (n=40) of patients had a weight for age less than the fifth percentile, while the mean weight was 23.2 ± 10 kg. Approximately half of the patients had the illness for one month before getting diagnosed with this condition. Other demographic features are mentioned in Table [1](#TAB1){ref-type="table"}.

###### Demographic characteristics of children presenting with critical mediastinal mass (n=61)

n, sample size.

  ------------------------------------ -----------------------
  Variable                             n (%)
  Age groups                            
  2-5 years                            11 (18.0)
  6-10 years                           33 (54.1)
  \>10 years                           17 (27.9)
  Gender                                
  Male                                 42 (68.9)
  Female                               19 (31.1)
  Ethnicity                             
  Sindhi                               31 (50.8)
  Punjabi                              01 (1.6)
  Balochi                              18 (29.5)
  Not known                            11 (18.0)
  Weight (kg) mean ± SD                23.2 ± 10
  Malnourished                          
  Yes                                  40 (65.6)
  No                                   21 (34.4)
  Duration of illness                   
  \<1 week                             08 (13.1)
  1-2 weeks                            09 (14.8)
  \>2-3 weeks                          03 (4.9)
  \>3-4 weeks                          11 (18.0)
  \>4 weeks                            30 (49.2)
  Length of stay in days (mean ± SD)   6 ± 5.23 (range 1-32)
  ------------------------------------ -----------------------

Most of these children presented with nonspecific symptoms such as fatigue (63.9%), followed by weight loss, respiratory distress, cough, while fever (96.7%) and lymphadenopathy (82%) were the most frequent clinical signs present (Table [2](#TAB2){ref-type="table"}). Six (9.8%) patients had superior vena cava syndrome.

###### Clinical characteristics of children presenting with critical mediastinal mass (n=61)

^a^Other symptoms include chest pain, dysphagia, night sweats, and wheeze.

^b^Other clinical signs include facial swelling, upper body edema, stridor, ronchi, and decreased level of consciousness.

n, sample size; SVCS, superior vena cava syndrome.

  ------------------------- -----------
  Clinical characteristic   n (%)
  Presenting symptoms        
  Cough                     16 (26.2)
  Respiratory distress      18 (29.5)
  Weight loss               23 (37.7)
  Fatigue                   39 (63.9)
  Headache                  13 (21.3)
  Others^a^                 07 (11.5)
  Clinical signs            
  Fever                     59 (96.7)
  Tachypnea                 44 (72.1)
  Decrease air entry        20 (32.8)
  Crepitations in lungs     15 (24.6)
  Desaturation              24 (39.3)
  Lymphadenopathy           50 (82.0)
  Hepatosplenomegaly        46 (75.4)
  SVCS                      06 (9.8)
  Other clinical signs^b^   19 (31.2)
  ------------------------- -----------

Our data showed the presence of hyperleukocytosis in 38 (62.3%) patients, while more than half of the children had positive findings on chest X-ray, including pleural effusion in 17 (27.9%) patients. Echocardiography done in 55 patients showed pericardial effusion in 54.6% of patients, while three cases had partial great vessel obstruction (Table [3](#TAB3){ref-type="table"}).

###### Laboratory characteristics of children presenting with critical mediastinal mass (n=61)

n, sample size; LDH, lactate dehydrogenase.

  --------------------------------------
  Laboratory characteristics
  Hematology profile 
  Hemoglobin (g/dL), (mean ± SD)
  Platelet counts
  \<50,000 (per mm^3^)
  50,000-100,000 (per mm^3^)
  \>100,000 (per mm^3^)
  Leucocyte counts
  \<10,000/mL
  10,000-50,000/mL
  51,000-100,000/mL
  \>100,000/mL
  Deranged coagulation profile
  Positive smear for blast cells 
  Serum potassium (mmol/L) (mean ± SD)
  Serum uric acid (mg/dL) (mean ± SD)
  Serum LDH (mini-max)
  Serum creatinine (mg/dL) (mean ± SD)
  Serum phosphate (mg/dL) (mean ± SD)
  Alanine aminotransferase (mean ± SD)
  Positive blood culture 
  Radiological profile
  Chest X-ray performed
  Effusion on chest X-ray
  Lung abnormalities
  CT-scan chest performed
  Effusion on CT chest
  Tracheal compression 
  Vessel compression
  Echocardiography done
  Pericardial effusion
  Vessel compression
  Ejection fraction (min-max)
  --------------------------------------

Figure [1](#FIG1){ref-type="fig"} shows that the most common diagnosis was T-cell acute lymphoblastic leukemia (72.1%), while 4.4% had lymphoblastic lymphoma. Peripheral blood flow cytometry was used to make the diagnosis in most (59%) of these children, followed by peripheral lymph node biopsy (13.1%). A total of 22 (32.6%) patients developed tumor lysis syndrome as a complication. The mean length of hospital stay was 6 ± 5.2 days. Analysis of the outcomes revealed that mortality was observed in 10 (16.4%) patients, while all six patients in our cohort, who were put on mechanical ventilation, did not survive (Table [4](#TAB4){ref-type="table"}).

![Diagnosis in patients with anterior mediastinal masses (n=61)\
\*Neuroblastoma, Ewing sarcoma, B-cell non-Hodgkin's lymphoma, suspected leukemia died before diagnosis, and suspected Hodgkin's lymphoma.\
T-ALL, T-cell acute lymphoblastic leukemia.](cureus-0012-00000008838-i01){#FIG1}

###### Mode of diagnosis, intervention, and outcome of children presenting with critical mediastinal mass (n=61)

n, sample size; TLS, tumor lysis syndrome; LP, lumbar puncture.

  -------------------------------------- -----------
  Characteristic                         n (%)
  Mode of diagnosis                       
  On peripheral blood flow cytometry     36 (59)
  On pleural fluid flow cytometry        01 (1.6)
  On mediastinal mass core biopsy        03 (4.9)
  On peripheral lymph node biopsy        08 (13.1)
  Complications                          
  Septic shock                           13 (21.3)
  Acute kidney injury on admission       05 (8.2)
  Acute kidney injury during treatment   07 (11.5)
  TLS                                    22 (36.1)
  Clinical TLS                           02 (9.1)
  Laboratory TLS                         16 (72.7)
  Both clinical and laboratory TLS       05 (22.7)
  Intervention                           
  Cytoreduction                          60 (98.4)
  Chemotherapy                           35 (58.3)
  Both chemotherapy and LP               25 (41.7)
  Pre-treatment steroids                 04 (6.6)
  Inotropic support                      08 (13.1)
  Mechanical ventilation                 06 (9.8)
  Dialysis                               02 (3.3)
  Cardiopulmonary resuscitation          04 (6.6)
  Outcome                                
  Mortality                              10 (16.4)
  -------------------------------------- -----------

A univariate logistic regression analysis was calculated to predict participants\' outcomes based upon other variables such as age, gender, nutritional status, duration of symptom, diagnosis, total leukocyte count, platelet count, and mechanical ventilation. We found a non-significant relationship between all the other predictor values (p-value \>0.05), except mechanical ventilation and the mortality outcome (p-value \<0.001) (Table [5](#TAB5){ref-type="table"}).

###### Univariate logistic regression analysis for determinants of mortality in children presenting with critical mediastinal mass (n=61)

n, sample size; T-ALL, T-cell acute lymphoblastic leukemia.

  ------------------------ ------------ ------------
  Determinant              Odds ratio   95% CI
  Age (yrs)                0.81         0.65-1.00
  Gender                                 
  Male                     1            \-
  Female                   1.07         0.24-4.67
  Malnourished                           
  No                       1            \-
  Yes                      0.79         0.18-3.41
  Duration of symptoms                   
  Up to 2 weeks            1            \-
  \>2-4 weeks              0.54         0.09-2.94
  \>4 weeks                1.93         0.34-10.83
  Diagnosis                              
  Others                   1            \-
  T-ALL                    3.25         0.80-13.16
  Total leucocyte count                  
  \<100,000/mL             1            \-
  ≥100,000/mL              0.79         0.18-3.42
  Platelet count                         
  \>100,000 (per mm^3^)    1            \-
  \<100,000 (per mm^3^)    0.81         0.15-4.36
  Mechanical ventilation                 
  Yes                      2.5          1.17-5.34
  No                       1            \-
  ------------------------ ------------ ------------

Discussion
==========

This is the first comprehensive report on children with CMMS from a PICU of a lower middle-income country. We found that the mortality rate was 16.4% (n=10) in children with CMMS. The compressive effects of these masses on the airways or the great vessels owing to small intra-thoracic volume in young children can lead to cardiorespiratory compromise, resulting in death. Various studies report 25%-45% mortality in these patients \[[@REF11],[@REF12]\].

T-cell acute lymphoblastic leukemia was the most common malignancy (72%, n=44) in our cohort of CMMS. Kashif et al. found T-cell acute lymphoblastic leukemia in 35% of children with a malignant mediastinal mass and found it to be the strongest risk factor for mortality (p \<0.001) \[[@REF11]\]. The reported mortality was 45% in their report. In another report from India, Mathan and Ananthamurthy described 53.3% of T-cell acute lymphoblastic leukemia in their children with mediastinal mass \[[@REF13]\]. Similarly, Ravindranath et al. observed very high mortality in acute lymphoblastic leukemia with a mediastinal mass \[[@REF14]\]. However, the prognostic significance of mediastinal mass in T-cell acute lymphoblastic leukemia is controversial. We did not find any association of mortality with primary diagnosis in any study.

The most striking clinical observation of this report is that the controlled positive pressure ventilation with muscle paralysis in these patients was associated with 100% mortality (p \<0.001). The positive pressure ventilation with neuromuscular blockade is detrimental, further aggravating airway obstruction and leading to cardiovascular collapse from fatal airway obstruction, which is not amenable to routine cardiopulmonary resuscitation in the absence of rigid bronchoscopy and extracorporeal life-support system. There are multiples reasons for fatal airway obstruction in children with CMMS, including small lung volume, loss of spontaneous diaphragmatic activity, decrease in chest wall muscle tone, the position of the patient, and compression effect of the tumor on airway distal to the endotracheal tube. Previously published reports demonstrated that spontaneous ventilation is ideal in such patients \[[@REF15]-[@REF17]\].

The most important dilemma of determining the primary diagnosis in such life-threatening cases is challenging and needs a multidisciplinary team approach like anesthesia, interventional radiologist, and pediatric thoracic surgeon. In most cases, the alternative tissue was used for primary diagnosis and rarely needed mediastinal tissue biopsy as in many clinical reports on symptomatic mediastinal mass in children. In our study, we established the primary diagnosis from alternative tissue: 59% from peripheral blood flow cytometry and 13% from cervical lymph node biopsy. Hence, mediastinal tissue biopsy was needed in only 5% of cases. Garey et al. in their study diagnosed all patients with T-cell acute lymphoblastic leukemia on either peripheral blood smear (50%) or bone marrow aspiration (50%) \[[@REF7]\]. Acker et al. included 69 children with an anterior mediastinal mass and most cases (81%) needed a biopsy tissue from outside the mediastinum with minimal sedation and spontaneous breathing \[[@REF18]\].

Clinically, children with mediastinal masses are often symptomatic of both respiratory and constitutional symptoms because of malignancy. They are treated initially for common respiratory illnesses like pneumonia and asthma \[[@REF12]\]. Lam et al. analysed clinical records of 29 children with mediastinal mass, and an anteriorly located mass was a significant factor to develop respiratory compromise (p=0.019) \[[@REF6]\]. A total of 24.1% of children were asymptomatic at the time of diagnosis. Symptomatic children presented with cough (33.3%), dyspnea (23.8%), and chest pain (19%), while one patient developed wheeze \[[@REF6]\]. Our results show that most children had non-specific symptoms such as fatigue, weight loss, and cough while fever and tachypnea were the most common clinical manifestations. These results are comparable to other studies \[[@REF6],[@REF12],[@REF19],[@REF20]\]. The demographic analysis showed the mean age at diagnosis to be 9 years, higher than that seen in the existing literature \[[@REF11],[@REF21]\]. Among the patients in this study, tumor lysis syndrome was the most common (36.1%) followed by septic shock (21%) and acute kidney injury (11%).

This study comprehensibly reviews the PICU course of CMMS in children and further strengthens the existing literature. Study limitations included retrospective data collection from a single institution and a small sample size.

Conclusions
===========

We found that the 100% fatality rate with controlled positive pressure ventilation and spontaneous breathing is ideal. Tumor lysis syndrome was the most common morbidity in our cohort. The rapid use of alternative tissue for primary diagnosis in most cases and the early initiation of intensive chemotherapy may improve the outcome in these children.
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